Technical analysis of CRISPR Therapeutics AG (CRSP): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases. The company achieves this through its exclusive Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology, which enables precise and targeted alterations to an organism's genetic code.
Price Performance
| 1 month | -9.81% |
| 3 months | -4.69% |
| Year-to-date | -4.67% |
| 1 year | -19.33% |
| 3 years | -1.96% |
| 5 years | -46.25% |
| 10 years | +228.88% |
52-Week Range
| 52-week High | $65.98 |
| 52-week Low | $44.12 |
| Avg Volume (90d) | 1.6M |
Technical Indicators
| SMA 50 | $54.00 |
| SMA 200 | $52.86 |
| Beta | 1.79 |
| 30-day Volatility (annualised) | 49.4% |
| Price vs SMA 50 | -7.4% |
| Price vs SMA 200 | -5.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $52.44 | |
| 2026-01 | $49.96 | -4.7% |
| 2026-02 | $60.14 | +20.4% |
| 2026-03 | $47.57 | -20.9% |
| 2026-04 | $52.34 | +10.0% |
| 2026-05 | $56.18 | +7.3% |
| 2026-06 | $54.54 | -2.9% |
| 2026-07 | $47.99 | -12.0% |
| 2026-08 | $56.98 | +18.7% |
| 2026-09 | $55.32 | -2.9% |
| 2026-10 | $51.42 | -7.0% |
| 2026-11 | $49.99 | -2.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-09 | $-1.04 | $15M |
| 2026-08-03 | $-1.19 | $7M |
| 2026-05-04 | $-1.19 | $6M |
| 2026-02-12 | $-1.15 | $5M |
| 2025-11-10 | $-1.26 | $9M |
| 2025-08-05 | $-1.47 | $6M |
| 2025-05-06 | $-1.27 | $6M |
Price
| Price | $49.99 (closing price, November 2, 2026) |
| Market Cap | $4.8B |
| Exchange | NASDAQ |
| Country | CH |
Valuation Ratios
| Price / Book | 2.93 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.47 |
| Current Ratio | 16.12 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 7.18 |